Walters TR, Kothe AC, Boyer JL, Usner DW, et al. A Randomized, Controlled Comparison of NCX 470 (0.021%, 0.042% and 0.065%) and Latanoprost 0.005% in Patients with Open-Angle Glaucoma or Ocular Hypertension: The Dolomites Study. J Glaucoma 2022 Apr 6. pii: 00061198-990000000-00006.
PMID: 35394456